Navigating the Biospecimen Ecosystem for Cell Therapies

Abstract

Get full access to this article

View all access options for this article.

References

Alliance for Regenerative Medicine and the National Institute for Innovation in Manufacturing Biopharmaceuticals. Project A-Gene: A case study-based approach to integrating QbD principles in gene therapy CMC programs. Published June 24, 2021. Accessed December 1, 2022. https://alliancerm.org/manufacturing/a-gene-2021.

Meneghel

, Kilbride

, Morris

. Cryopreservation as a Key Element in the Successful Delivery of Cell-Based Therapies—A Review. Front. Med. (Lausanne) , 2020; 7: 592242. DOI: 10.3389/fmed.2020.592242.

U.S. Food and Drug Administration. Long Term Follow-Up After Administration of Human Gene Therapy Products. Guidance for Industry. Published January 30, 2020. Accessed December 1, 2022. https://www.fda.gov/media/113768/download.

King

, Schwartz

, Pincus

, Forsberg

. Viral Vector Characterization: A Look at Analytical Tools. Cell Culture Dish . Published October 10, 2018. Accessed December 1, 2022. https://cellculturedish.com/viral-vector-characterization-analytical-tools/.

Gene therapy needs a long-term approach. Nat. Med. , 2021; 27: 563. DOI: 10.1038/s41591-021-01333-6.

Lindgren

, Leinbach

, Annis

, et al. Processing laboratory considerations for multi-center cellular therapy clinical trials: A report from the Consortium for Pediatric Cellular Immunotherapy. Cytotherapy , 2021; 23(2): 157–164. DOI: 10.1016/j.jcyt.2020.09.013.

Harrison

, Rafiq

, Medcalf

. Centralised versus decentralised manufacturing and the delivery of healthcare products: A United Kingdom exemplar. Cytotherapy , 2018; 20(6): 873–890. DOI: 10.1016/j.jcyt.2018.05.003.